Articles producció científica> Ciències Mèdiques Bàsiques

Species diversity of Aspergillus section Versicolores in clinical samples and antifungal susceptibility

  • Dades identificatives

    Identificador: PC:1866
    Autors:
    Siqueira J, Sutton D, García D, Gené J, Thomson P, Wiederhold N, Guarro J
    Resum:
    Filiació URV: SIInclòs a la memòria: SI
  • Altres:

    Autor segons l'article: Siqueira J, Sutton D, García D, Gené J, Thomson P, Wiederhold N, Guarro J
    Departament: Ciències Mèdiques Bàsiques
    Autor/s de la URV: GARCÍA SÁNCHEZ, DANIA; Joao Paulo Zen SIQUEIRA; Deanna A. SUTTON; GENÉ DÍAZ, JOSEPA; Pamela THOMSON; Nathan WIEDERHOLD; GUARRO ARTIGAS, JOSEP
    Paraules clau: taxonomy Aspergilli Ascomycetes
    Resum: Aspergillus section Versicolores includes species of clinical relevance and many others that have been poorly studied but are occasionally found in clinical samples. The aim of this study was to investigate, using a multilocus phylogenetic approach, the spectrum of species of the section Versicolores and to determine their in vitro antifungal susceptibility. The study was based on a set of 77 clinical isolates from different USA medical centres, which had been previously identified as belonging to this section. The genetic markers used were internal transcribed spacer (ITS), β-tubulin (BenA), calmodulin (CaM), and RNA polymerase II second largest subunit (RPB2), and the drugs tested, following the CLSI guidelines, were amphotericin B (AMB), itraconazole, posaconazole, voriconazole, anidulafungin, caspofungin, micafungin, terbinafine (TBF), and flucytosine (5FC). The most frequent species were Aspergillus sydowii (26 %), Aspergillus creber (22 %), and Aspergillus amoenus (18.2 %), followed by Aspergillus protuberus (13 %), Aspergillus jensenii (10.4 %), and Aspergillus tabacinus (5.2 %); while Aspergillus cvjetkovicii, Aspergillus fructus, Aspergillus puulaauensis, and Aspergillus versicolor were represented by only one isolate each (1.3 %). This is the first time that A. jensenii and A. puulaauensis have been reported from clinical samples. Considering the high number of isolates identified as belonging to this fungal group in this study, its clinical relevance should not be overlooked. Aspergillus versicolor, traditionally considered one of the most common species in this section in a clinical setting, was only rarely recovered in our study. The in vitro antifungal results showed that echinocandins and TBF were the most potent drugs, the azoles showed variable results, AMB was poorly active, and 5FC was the less active.
    Grup de recerca: Unitat de Micologia i Microbiologia Ambiental
    Àrees temàtiques: Health sciences Ciencias de la salud Ciències de la salut
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 1878-6146
    Data d'alta del registre: 2016-11-10
    Pàgina final: 1467
    Volum de revista: 120
    Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
    Enllaç font original: https://www.sciencedirect.com/science/article/pii/S187861461600043X?via%3Dihub
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    DOI de l'article: 10.1016/j.funbio.2016.02.006
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2016
    Pàgina inicial: 1458
    Tipus de publicació: Article Artículo Article
  • Paraules clau:

    Ascomicets
    Aspergil·lus
    Taxonomia
    taxonomy
    Aspergilli
    Ascomycetes
    Health sciences
    Ciencias de la salud
    Ciències de la salut
    1878-6146
  • Documents:

  • Cerca a google

    Search to google scholar